Encompass Wealth Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-18,621
Closed -$498K 243
2022
Q1
$498K Buy
18,621
+5,121
+38% +$121K 0.13% 131
2021
Q4
$349K Buy
13,500
+4,805
+55% +$120K 0.08% 170
2021
Q3
$204K Buy
+8,695
New +$304K 0.05% 214

Other funds holding PRVA

Encompass Wealth Advisors's PRVA Position: Q2 2022 in Review

Encompass Wealth Advisors sold out of Privia Health (PRVA) in Q2 2022, closing a stake of 18,621 shares — an estimated $498K sold.

Encompass Wealth Advisors first reported a position in PRVA in Q3 2021 and held it in 3 quarters. The position peaked at $498K in Q1 2022. 151 funds tracked by Wall St. Rank hold PRVA as of Q2 2022.

  • Encompass Wealth Advisors reported no remaining Privia Health position as of Q2 2022 after selling out during the quarter.
  • Encompass Wealth Advisors sold 18,621 Privia Health shares in Q2 2022, an estimated $498K.
  • Encompass Wealth Advisors first reported a position in Privia Health in Q3 2021 and held it in 3 quarters.
  • Encompass Wealth Advisors's Privia Health position peaked at $498K in Q1 2022.
  • 151 funds tracked by Wall St. Rank held Privia Health as of Q2 2022.

Based on Encompass Wealth Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.